Arginine Reducing Therapies

I've already gotten rid of my prescription and my family doctor is going to switch my med's to this brand. Thanks for all your work and for getting the word out. Effect of the ivermectin oral treatment for goats of the genera capra hircus, capra aegagrus hircus, and capra ibex on the reproductive parameters.

Purchase travel with your discover card at thousands of retail stores, including kmart, wal-mart, k-mart, and many other merchants. The first step is to get the patient to the doctor, where a comprehensive evaluation of symptoms, vilitra 60 mg kaufen signs, and any risk factors that are present can help identify those who are likely to respond to treatment and those at high risk for progression. But no matter what you decide to take, we'll help you find the right type of skin care for your skin type.

More info about license types

Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no), delivery costs do not apply.

You can also order this product via email or fax, please download the Order Form

Publisher: La Merie Publishing
Format: Word Table
Product Line: Target Pipeline List
Product Code: LMTPL040
Release Date: April of 2019

Arginine Reducing Therapies – Target Pipeline List 04/2019

Targets: Arginine

This Target Pipeline List provides an overview of therapeutic proteins in development for treatment of arginine-dependent tumors or for enzyme replacement therapy.

Amino acid deprivation is a validated approach for controlling tumor growth. Arginine is an essential amino acid to many tumor types, however, many of these malignancies lack the relevant metabolic enzymes, such as argininosuccinate synthetase (ASS) and/or ornithine transcarbamylase (OTC), to produce arginine. These OTC and/or ASS deficient tumors are therefore completely dependent upon external sources of arginine, making arginine deprivation therapy an attractive strategy for tumor treatment.

Arginase 1 Deficiency is a rare genetic disorder caused by a mutation in the Arginase 1 gene that leads to the inability to degrade arginine. This results in excessively high levels of arginine in the blood, referred to as hyperargininemia. Replacement of the Arginase 1 missing in patients and reduce elevated blood arginine levels to the normal physiological range. Normalization of arginine levels is anticipated to slow or halt the progression of disease in these patients.

La Merie Publishing offers a low-cost product service providing information about active R&D projects for a given target in the format of Word tables.

The Word document with the Table is delivered by e-mail within 24 hours after receipt of the confirmed order. Usually, delivery time is less than one hour if ordered during European business hours.

Download information leaflet about deliverable and methodology of Target Pipeline Lists.

Single User License:

This license allows for use of a report by one named person, explicitly confirmed at point of sale

Departmental License:

This license allows for use of a report by members of the same Dept within the same enterprise location or of the same international Project Group.

Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise location.

Global Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise worldwide.


Custom Support & Sale:

Mon–Fri: 10:00 am –5:00 pm GMT+01